Skip to main content

Evaluation and Management of Patients Referred for Post-Bariatric Surgery Hypoglycemia at a Tertiary Care Center

Obesity Surgery volume 32, pages 1578–1585 (2022)Cite this article

Abstract

Purpose

Following bariatric surgery, patients can develop non-specific symptoms self-described as hypoglycemia. However, confirming hypoglycemia can be technically challenging, and therefore, these individuals are frequently treated empirically. This study aimed to describe what diagnostic evaluation and therapeutic interventions patients referred for post-bariatric surgery hypoglycemia undergo.

Methods

Retrospective observational cohort study of patients with a history of bariatric surgery was evaluated for post-bariatric surgery hypoglycemia in a tertiary referral center from 2008 to 2017. We collected demographic and bariatric surgery information, clinical presentation of symptoms referred to as hypoglycemia, laboratory and imaging studies performed to evaluate these symptoms, and symptom management and outcomes.

Results

A total of 60/2450 (2.4%) patients who underwent bariatric surgery were evaluated in the Department of Endocrinology for hypoglycemia-related symptoms. The majority were middle-aged women without type 2 diabetes who had undergone Roux-en-Y gastric bypass. Thirty-nine patients (65%) completed a biochemical assessment for hypoglycemia episodes. Six (10%) had confirmed hypoglycemia by Whipple’s triad, and four (6.7%) met the criteria for post-bariatric surgery hypoglycemia based on clinical and biochemical criteria. All patients were recommended dietary modification as the initial line of treatment, and this intervention resulted in most patients reporting at least some improvement in their symptoms. Eight patients (13%) were prescribed pharmacotherapy, and two patients required additional interventions for symptom control.

Conclusions

In our experience, evaluation for hypoglycemia-related symptoms after bariatric surgery was rare. Hypoglycemia was confirmed in the minority of patients. Even without establishing a diagnosis of hypoglycemia, dietary changes were a helpful strategy for symptom management for most patients.

Graphical abstract

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

Abbreviations

BMI:

Body mass index

PGBH:

Post-gastric bypass surgery hypoglycemia

RYGB:

Roux-en-Y gastric bypass

TBWL:

Total body weight loss

References

  1. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.

    Article  Google Scholar 

  2. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. Jama. 2012;307(1):56–65. https://doi.org/10.1001/jama.2011.1914 [published Online First: Epub Date]|.

  3. Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet. 2021;397(10271):293–304.

    Article  Google Scholar 

  4. Carlsson LM, Sjöholm K, Jacobson P, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383(16):1535–43.

    Article  Google Scholar 

  5. Nielsen JB, Pedersen AM, Gribsholt SB, Svensson E, Richelsen B. Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(8):1562–8.

    Article  Google Scholar 

  6. van Beek AP, Emous M, Laville M, Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev. 2017;18(1):68–85. https://doi.org/10.1111/obr.12467. [published Online First: Epub Date]|.

  7. Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol. 2009;6(10):583–90. https://doi.org/10.1038/nrgastro.2009.148 [published Online First: Epub Date]|.

  8. Mathews DH, Lawrence W Jr, Poppell JW, Vanamee P, Randall HT. Change in effective circulating volume during experimental dumping syndrome. Surgery. 1960;48:185–94.

    CAS  PubMed  Google Scholar 

  9. Shah M, Law JH, Micheletto F, et al. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014;63(2):483–93. https://doi.org/10.2337/db13-0954 [published Online First: Epub Date]|.

  10. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92(12):4678–85. https://doi.org/10.1210/jc.2007-0918 [published Online First: Epub Date]|.

  11. Bantle JP, Ikramuddin S, Kellogg TA, Buchwald H. Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg. 2007;17(5):592–4. https://doi.org/10.1007/s11695-007-9102-6 [published Online First: Epub Date]|.

  12. Salehi M, Vella A, McLaughlin T, Patti M-E. Hypoglycemia after gastric bypass surgery: current concepts and controversies. J Clin Endocrinol Metab. 2018;103(8):2815–26. https://doi.org/10.1210/jc.2018-00528 [published Online First: Epub Date]|.

  13. Suhl E, Anderson-Haynes S-E, Mulla C, Patti M-E. Medical nutrition therapy for post-bariatric hypoglycemia: practical insights. Surg Obes Relat Dis. 2017;13(5):888–96.

    Article  Google Scholar 

  14. Ohrstrom CC, Worm D, Hojager A, et al. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diabetes Obes Metab. 2019;21(9):2142–51. https://doi.org/10.1111/dom.13796 [published Online First: Epub Date]|.

  15. Özgen AG, Hamulu F, Bayraktar F, et al. Long-term treatment with acarbose for the treatment of reactive hypoglycemia. Eat Weight Disord Stud Anorexia Bulimia Obes. 1998;3(3):136–40.

    Article  Google Scholar 

  16. Moreira RO, Moreira RB, Machado NA, Gonçalves TB, Coutinho WF. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg. 2008;18(12):1618–21.

    Article  Google Scholar 

  17. Zanley E, Shah ND, Craig C, Lau JN, Rivas H, McLaughlin T. Guidelines for gastrostomy tube placement and enteral nutrition in patients with severe, refractory hypoglycemia after gastric bypass. Surg Obes Relat Dis. 2020.

  18. Carter CO, Fernandez AZ, McNatt SS, Powell MS. Conversion from gastric bypass to sleeve gastrectomy for complications of gastric bypass. Surg Obes Relat Dis. 2016;12(3):572–6.

    Article  Google Scholar 

  19. Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinol Metab Clin North Am. 1999;28(3):519–32, vi. https://doi.org/10.1016/s0889-8529(05)70086-4 [published Online First: Epub Date]|.

  20. Sarwar H, Chapman WH, Pender JR, et al. Hypoglycemia after Roux-en-Y gastric bypass: the BOLD experience. Obes Surg. 2014;24(7):1120–4.

    Article  Google Scholar 

  21. Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008;4(4):492–9. https://doi.org/10.1016/j.soard.2008.05.005 [published Online First: Epub Date]|.

  22. Marsk R, Jonas E, Rasmussen F, Näslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. 2010;53(11):2307–11. https://doi.org/10.1007/s00125-010-1798-5 [published Online First: Epub Date]|.

  23. Lee CJ, Wood GC, Lazo M, et al. Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: a single center experience. Obesity. 2016;24(6):1342–48. https://doi.org/10.1002/oby.21479 [published Online First: Epub Date]|.

  24. Hanipah ZN, Punchai S, Birriel TJ, et al. Clinical features of symptomatic hypoglycemia observed after bariatric surgery. Surg Obes Relat Dis. 2018;14(9):1335–9.

    Article  Google Scholar 

  25. Bienvenot R, Sirveaux MA, Nguyen-Thi PL, Brunaud L, Quilliot D. Symptomatic hypoglycemia after gastric bypass: incidence and predictive factors in a cohort of 1,138 consecutive patients. Obesity (Silver Spring). 2021. https://doi.org/10.1002/oby.23118 [published Online First: Epub Date]|.

  26. Eisenberg D, Azagury DE, Ghiassi S, Grover BT, Kim JJ. ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis. 2017;13(3):371–8.

    Article  Google Scholar 

  27. Michaels AD, Hunter Mehaffey J, Brenton French W, Schirmer BD, Kirby JL, Hallowell PT. Hypoglycemia following bariatric surgery: our 31-year experience. Obes Surg. 2017;27(12):3118–23. https://doi.org/10.1007/s11695-017-2734-2 [published Online First: Epub Date]|.

  28. Zweck E, Hepprich M, Donath MY. Predictors of postprandial hypoglycemia after gastric bypass surgery: a retrospective case-control study. Obes Surg. 2021. https://doi.org/10.1007/s11695-021-05277-1 [published Online First: Epub Date]|.

  29. Raverdy V, Baud G, Pigeyre M, et al. Incidence and predictive factors of postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Ann Surg. 2016;264(5):878–85.

    Article  Google Scholar 

  30. Belligoli A, Sanna M, Serra R, et al. Incidence and predictors of hypoglycemia 1 year after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(12):3179–86.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Lizeth Cifuentes and Maria D. Hurtado contributed equally to this work.

Authors and Affiliations

  1. Precision Medicine for Obesity Program, Mayo Clinic, 200 1st SW, Rochester, MN, 55905, USA

    Lizeth Cifuentes, Maria D. Hurtado & Andres Acosta

  2. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, 200 1st SW, Rochester, MN, 55905, USA

    Lizeth Cifuentes & Andres Acosta

  3. Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic Health System, 700 West Av. South, La Crosse, WI, 64601, USA

    Maria D. Hurtado

  4. Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA

    Maria D. Hurtado, Meera Shah & Maria L. Collazo-Clavell

  5. Division of Endocrinology, University of Texas Health, San Antonio, TX, 78229, USA

    Tiffany M. Cortes

  6. Division of Endocrinology, Diabetes, and Metabolism, University of New Mexico Health Sciences Center, Albuquerque, NM, 87106, USA

    Kristen Gonzales

Authors
  1. Lizeth Cifuentes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria D. Hurtado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tiffany M. Cortes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kristen Gonzales
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andres Acosta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Meera Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria L. Collazo-Clavell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria L. Collazo-Clavell.

Ethics declarations

Conflict of Interest

Andres Acosta is a stockholder in Gila Therapeutics, Phenomix Sciences; he served as a consultant for Rhythm Pharmaceuticals, General Mills. Lizeth Cifuentes, Maria D. Hurtado, Tiffany M. Cortes, Kristen Gonzales, Meera Shah, and Maria L. Collazo-Clavell declare that they have no conflicts of interest.

Statement of Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal informed consent is not required and does not apply.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• Post-bariatric surgery hypoglycemia is a rare post-surgical complication.

• Biochemical confirmation of post-bariatric surgery hypoglycemia is challenging in clinical practice.

• Dietary changes are a helpful strategy to manage symptoms in most patients; pharmacotherapy is reserved for cases that do not respond to dietary modification.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cifuentes, L., Hurtado, M.D., Cortes, T.M. et al. Evaluation and Management of Patients Referred for Post-Bariatric Surgery Hypoglycemia at a Tertiary Care Center. OBES SURG 32, 1578–1585 (2022). https://doi.org/10.1007/s11695-022-05986-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-022-05986-1